Jihan Sun

Jiangnan Road 1111, Yinzhou Strict
Ningbo, 315040, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Association between circadian syndrome and MASLD risk: evidence from a large cross-sectional study.

Association between circadian syndrome and MASLD risk: evidence from a large cross-sectional study.

Journal: BMC gastroenterology

Published: March 13, 2025

Metformin inhibits the proliferation of hepatocellular carcinoma cells through inducing ferroptosis analyzed by phosphoproteomics.

Metformin inhibits the proliferation of hepatocellular carcinoma cells through inducing ferroptosis analyzed by phosphoproteomics.

Journal: Frontiers in oncology

Published: November 20, 2024

The predictive value of the lymphocyte-C-reactive protein ratio for early recurrence in MVI positive HCC patients who underwent postoperative adjuvant transcatheter arterial chemoembolization.

The predictive value of the lymphocyte-C-reactive protein ratio for early recurrence in MVI positive HCC patients who underwent postoperative adjuvant transcatheter arterial chemoembolization.

Journal: BMC cancer

Published: November 18, 2024

PLD2 is a marker for MASLD-HCC with early-stage fibrosis: revealed by lipidomic and gene expression analysis.

PLD2 is a marker for MASLD-HCC with early-stage fibrosis: revealed by lipidomic and gene expression analysis.

Journal: Metabolomics : Official journal of the Metabolomic Society

Published: September 23, 2024

Simultaneous Activation of Beta-Oxidation and De Novo Lipogenesis in MASLD-HCC: A New Paradigm.

Simultaneous Activation of Beta-Oxidation and De Novo Lipogenesis in MASLD-HCC: A New Paradigm.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: September 16, 2024

Development of nomogram models of inflammatory markers based on clinical database to predict prognosis for hepatocellular carcinoma after surgical resection.

Development of nomogram models of inflammatory markers based on clinical database to predict prognosis for hepatocellular carcinoma after surgical resection.

Journal: BMC cancer

Published: September 05, 2021

Hsa_circ_0037897 may be a risk factor for essential hypertension via hsa-miR-145-5p.

Hsa_circ_0037897 may be a risk factor for essential hypertension via hsa-miR-145-5p.

Journal: Clinical and experimental hypertension (New York, N.Y. : 1993)

Published: December 14, 2020

The microarray identification circular RNA hsa_circ_0105015 up-regulated involving inflammation pathway in essential hypertension.

The microarray identification circular RNA hsa_circ_0105015 up-regulated involving inflammation pathway in essential hypertension.

Journal: Journal of clinical laboratory analysis

Published: July 10, 2020

The up-regulated hsa-circRNA9102-5 may be a risk factor for essential hypertension.

The up-regulated hsa-circRNA9102-5 may be a risk factor for essential hypertension.

Journal: Journal of clinical laboratory analysis

Published: November 27, 2019

A potential risk factor of essential hypertension in case-control study: MicroRNAs miR-10a-5p.

A potential risk factor of essential hypertension in case-control study: MicroRNAs miR-10a-5p.

Journal: Clinical and experimental hypertension (New York, N.Y. : 1993)

Published: February 02, 2019

Up-regulation of circular RNA hsa_circ_0037909 promotes essential hypertension.

Up-regulation of circular RNA hsa_circ_0037909 promotes essential hypertension.

Journal: Journal of clinical laboratory analysis

Published: October 15, 2018

Circular RNA hsa_circ_0014243 may serve as a diagnostic biomarker for essential hypertension.

Circular RNA hsa_circ_0014243 may serve as a diagnostic biomarker for essential hypertension.

Journal: Experimental and therapeutic medicine

Published: May 16, 2018

Showing 1-12 of 13

Last Updated: 09/26/2026